The effect of hemoperfusion on patients with severe symptoms of covid-19 which are resistant to conventional therapies

Investigaing the hemoperfusion effect on the recovery of hospitalized patients with severe COVID-19 symptoms in Imam Khomeini Hospital, Urmia; a before-after pilot study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180625040232N7

Enrollment

Registered

2020-11-30

Start date

2020-11-10

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hospitalized patients with COVID-19 symptoms. COVID-19, virus identified

Interventions

Intervention group: There is one intervention group that includes COVID-19 patients admitted with severe symptoms who are resistant to common medical treatments. These patients will undergo hemoperfus

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Covid-19 patients admitted with severe symptoms who do not respond to conventional therapies based on guidelines satiscfaction with performing of hemoperfusion lung involvement more than 50% according to Chest- CT imaging In patients with lungs involvement less than 50% with respiratory distress, or SO2 less than 88%, despite receiving supplementory oxygen with a reservoir mask or NIV

Exclusion criteria

Exclusion criteria: uncorrected coagulopathy in patients vasculitis sepsis Patients with low life expectancy due to underlying disease

Design outcomes

Primary

Measure	Time frame
Respiratory status regarding So2. Timepoint: After performing of two session hemoperfusion. Method of measurement: By pulse oximetry.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaman Farshid

Oroumia University of Medical Sciences

samanf63@gmail.com+98 44 3346 9931

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026